Dr. Evan Levine tackles a drug that is often prescribed to help children perform better — a phenomenon he calls “borderline ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.

Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

The focus is on a drug called Lepodisiran, that could target certain factors that increase risk of heart attacks and strokes.

A Peninsula biotech startup's acquisition of a Chicago health data firm could transform how heart drugs are developed, ...

Giving patients a combination of drugs earlier in their treatment could prevent thousands of heart attacks, a new study ...

The differences in risk of sudden cardiac death varied by age and how long people took antidepressants, with people taking ...

Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of ...

Bristol Myers Squibb BMY suffered a setback in the late-stage ODYSSEY-HCM study evaluating cardiovascular drug Camzyos (mavacamten). The phase III study was evaluating Camzyos for the treatment of ...